InsiderTrades

Form 4 for PFE Pfizer

Accepted 2021-08-02 00:00:00 ET · period of report 2021-07-30 · accession 0001225208-21-011033 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-02 2021-07-30 PFE DAMICO JENNIFER B. SVP, Ctrl S - Sale $42.86 -2,500 11.4K -18% -$107.2K
D 2021-08-02 2021-07-30 PFE DAMICO JENNIFER B. SVP, Ctrl A - Grant $42.81 +29 14.8K +0.2% +$1,241

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-30 S D 2,500 $42.86 11,430 D — —
2 Derivative Phantom Stock Units SSP 2021-07-30 A A 29 $42.81 14,824 D — · — to — 29 Common Stock (F1) Each unit represents one phantom share of common stock. (F2) These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.